Vector viral (Galician Wikipedia)

Analysis of information sources in references of the Wikipedia article "Vector viral" in Galician language version.

Last modified: 18:58:22, 17 October 2026 (UTC)

Ref.Un. Ref.Website

Global rank Galician rank

1816nih.gov

5^th place

2^nd place

1816doi.org

2^nd place

3^rd place

98archive.org

6^th place

4^th place

11scientificamerican.com

1,110^th place

472^nd place

11web.archive.org

1^st place

11newscientist.com

1,041^st place

352^nd place

11nejm.org

2,717^th place

1,100^th place

11tandfonline.com

286^th place

323^rd place

11worldcat.org

4^th place

7^th place

archive.org (Global: 6^th place; Galician: 4^th place)

Cavazzana-Calvo, M.; Hacein-Bey, S.; De Saint Basile, G.; Gross, F.; Yvon, E.; Nusbaum, P.; Selz, F.; Hue, C.; Certain, S.; Casanova, J. L.; Bousso, P.; Deist, F. L.; Fischer, A. (2000). "Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease". Science 288 (5466): 669–672. PMID 10784449. doi:10.1126/science.288.5466.669.
Hacein-Bey-Abina, S.; Le Deist, F. O.; Carlier, F. D. R.; Bouneaud, C. C.; Hue, C.; De Villartay, J. P.; Thrasher, A. J.; Wulffraat, N.; Sorensen, R.; Dupuis-Girod, S.; Fischer, A.; Davies, E. G.; Kuis, W.; Leiva, L.; Cavazzana-Calvo, M. (2002). "Sustained Correction of X-Linked Severe Combined Immunodeficiency by ex Vivo Gene Therapy". New England Journal of Medicine 346 (16): 1185–1193. PMID 11961146. doi:10.1056/NEJMoa012616.
Hacein-Bey-Abina, S.; Von Kalle, C.; Schmidt, M.; McCormack, M. P.; Wulffraat, N.; Leboulch, P.; Lim, A.; Osborne, C. S.; Pawliuk, R.; Morillon, E.; Sorensen, R.; Forster, A.; Fraser, P.; Cohen, J. I.; De Saint Basile, G.; Alexander, I.; Wintergerst, U.; Frebourg, T.; Aurias, A.; Stoppa-Lyonnet, D.; Romana, S.; Radford-Weiss, I.; Gross, F.; Valensi, F.; Delabesse, E.; MacIntyre, E.; Sigaux, F.; Soulier, J.; Leiva, L. E.; Wissler, M. (2003). "LMO2-Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1". Science 302 (5644): 415–419. PMID 14564000. doi:10.1126/science.1088547.
Montini, E.; Cesana, D.; Schmidt, M.; Sanvito, F.; Ponzoni, M.; Bartholomae, C.; Sergi Sergi, L. S.; Benedicenti, F.; Ambrosi, A.; Di Serio, C.; Doglioni, C.; Von Kalle, C.; Naldini, L. (2006). "Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration". Nature Biotechnology 24 (6): 687–696. PMID 16732270. doi:10.1038/nbt1216.
Nussbaum, Robert L; McInnes, Roderick R; Willard, Huntington F (2015). Thompson & Thompson Genetics in Medicine. Canada: ELSEVIER. p. 278. ISBN 978-1-4377-0696-3.
Zhou, H. S.; Liu, D. P.; Liang, C. C. (2004). "Challenges and strategies: The immune responses in gene therapy". Medicinal Research Reviews 24 (6): 748–761. PMID 15250039. doi:10.1002/med.20009.
Crommelin DJ, Sindelar RD, Meibohm B (2008). Pharmaceutical Biotechnology: Fundamentals and application. Londres: Taylor & Francis. ISBN 1420044370.
Yang, Z. -Y.; Wyatt, L. S.; Kong, W. -P.; Moodie, Z.; Moss, B.; Nabel, G. J. (2003). "Overcoming Immunity to a Viral Vaccine by DNA Priming before Vector Boosting". Journal of Virology 77 (1): 799–803. PMC 140625. PMID 12477888. doi:10.1128/JVI.77.1.799-803.2003.

doi.org (Global: 2^nd place; Galician: 3^rd place)

dx.doi.org

Goff, S.; Berg, P. (1976). "Construction of hybrid viruses containing SV40 and λ phage DNA segments and their propagation in cultured monkey cells". Cell 9 (4): 695–705. PMID 189942. doi:10.1016/0092-8674(76)90133-1.
Hacein-Bey-Abina S, Hauer J, Lim A, Picard C, Wang GP, Berry CC, Martinache C, Rieux-Laucat F, Latour S, Belohradsky BH, Leiva L, Sorensen R, Debré M, Casanova JL, Blanche S, Durandy A, Bushman FD, Fischer A, Cavazzana-Calvo M (22 de xullo de 2010). "Efficacy of Gene Therapy for X-Linked Severe Combined Immunodeficiency". New England Journal of Medicine 363 (4): 355–364. PMC 2957288. PMID 20660403. doi:10.1056/NEJMoa1000164. Consultado o 13 de abril de 2013.
Sasmita, Andrew Octavian (2018-10-14). "Current viral-mediated gene transfer research for treatment of Alzheimer’s disease". Biotechnology and Genetic Engineering Reviews (en inglés): 1–20. ISSN 0264-8725. doi:10.1080/02648725.2018.1523521.
Cavazzana-Calvo, M.; Hacein-Bey, S.; De Saint Basile, G.; Gross, F.; Yvon, E.; Nusbaum, P.; Selz, F.; Hue, C.; Certain, S.; Casanova, J. L.; Bousso, P.; Deist, F. L.; Fischer, A. (2000). "Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease". Science 288 (5466): 669–672. PMID 10784449. doi:10.1126/science.288.5466.669.
Hacein-Bey-Abina, S.; Le Deist, F. O.; Carlier, F. D. R.; Bouneaud, C. C.; Hue, C.; De Villartay, J. P.; Thrasher, A. J.; Wulffraat, N.; Sorensen, R.; Dupuis-Girod, S.; Fischer, A.; Davies, E. G.; Kuis, W.; Leiva, L.; Cavazzana-Calvo, M. (2002). "Sustained Correction of X-Linked Severe Combined Immunodeficiency by ex Vivo Gene Therapy". New England Journal of Medicine 346 (16): 1185–1193. PMID 11961146. doi:10.1056/NEJMoa012616.
Hacein-Bey-Abina, S.; Von Kalle, C.; Schmidt, M.; McCormack, M. P.; Wulffraat, N.; Leboulch, P.; Lim, A.; Osborne, C. S.; Pawliuk, R.; Morillon, E.; Sorensen, R.; Forster, A.; Fraser, P.; Cohen, J. I.; De Saint Basile, G.; Alexander, I.; Wintergerst, U.; Frebourg, T.; Aurias, A.; Stoppa-Lyonnet, D.; Romana, S.; Radford-Weiss, I.; Gross, F.; Valensi, F.; Delabesse, E.; MacIntyre, E.; Sigaux, F.; Soulier, J.; Leiva, L. E.; Wissler, M. (2003). "LMO2-Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1". Science 302 (5644): 415–419. PMID 14564000. doi:10.1126/science.1088547.
Marini, B.; Kertesz-Farkas, A.; Ali, H.; Lucic, B.; Lisek, K.; Manganaro, L.; Pongor, S.; Luzzati, R.; Recchia, A.; Mavilio, F.; Giacca, M.; Lusic, M. (2015). "Nuclear architecture dictates HIV-1 integration site selection". Nature 521: 227–231. PMID 25731161. doi:10.1038/nature14226.
Cattoglio, C.; Facchini, G.; Sartori, D.; Antonelli, A.; Miccio, A.; Cassani, B.; Schmidt, M.; Von Kalle, C.; Howe, S.; Thrasher, A. J.; Aiuti, A.; Ferrari, G.; Recchia, A.; Mavilio, F. (2007). "Hot spots of retroviral integration in human CD34+ hematopoietic cells". Blood 110 (6): 1770–1778. PMID 17507662. doi:10.1182/blood-2007-01-068759.
Montini, E.; Cesana, D.; Schmidt, M.; Sanvito, F.; Ponzoni, M.; Bartholomae, C.; Sergi Sergi, L. S.; Benedicenti, F.; Ambrosi, A.; Di Serio, C.; Doglioni, C.; Von Kalle, C.; Naldini, L. (2006). "Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration". Nature Biotechnology 24 (6): 687–696. PMID 16732270. doi:10.1038/nbt1216.
Ramos-Kuri, M; Rapti, K; Mehel, H; Zhang, S; Dhandapany, PS; Liang, L; García-Carrancá, A; Bobe, R; Fischmeister, R; Adnot, S; Lebeche, D; Hajjar, RJ; Lipskaia, L; Chemaly, ER (2015). "Dominant negative Ras attenuates pathological ventricular remodeling in pressure overload cardiac hypertrophy". Biochim. Biophys. Acta 1853: 2870–84. PMID 26260012. doi:10.1016/j.bbamcr.2015.08.006.
McCarty, D M; Monahan, P E; Samulski, R J (2001). "Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis". Gene Therapy 8 (16): 1248–54. PMID 11509958. doi:10.1038/sj.gt.3301514.
Huang, S; Kamihira, M (2013). "Development of hybrid viral vectors for gene therapy.". Biotechnology advances 31 (2): 208–23. PMID 23070017. doi:10.1016/j.biotechadv.2012.10.001.
Nayak, S.; Herzog, R. W. (2009). "Progress and prospects: Immune responses to viral vectors". Gene Therapy 17 (3): 295–304. PMC 3044498. PMID 19907498. doi:10.1038/gt.2009.148.
Zhou, H. S.; Liu, D. P.; Liang, C. C. (2004). "Challenges and strategies: The immune responses in gene therapy". Medicinal Research Reviews 24 (6): 748–761. PMID 15250039. doi:10.1002/med.20009.
Yang, Z. -Y.; Wyatt, L. S.; Kong, W. -P.; Moodie, Z.; Moss, B.; Nabel, G. J. (2003). "Overcoming Immunity to a Viral Vaccine by DNA Priming before Vector Boosting". Journal of Virology 77 (1): 799–803. PMC 140625. PMID 12477888. doi:10.1128/JVI.77.1.799-803.2003.
Pandey, A.; Singh, N.; Vemula, S. V.; Couëtil, L.; Katz, J. M.; Donis, R.; Sambhara, S.; Mittal, S. K. (2012). Subbiah, Elankumaran, ed. "Impact of Preexisting Adenovirus Vector Immunity on Immunogenicity and Protection Conferred with an Adenovirus-Based H5N1 Influenza Vaccine". PLoS ONE 7 (3): e33428. PMC 3303828. PMID 22432020. doi:10.1371/journal.pone.0033428.

nejm.org (Global: 2,717^th place; Galician: 1,100^th place)

Hacein-Bey-Abina S, Hauer J, Lim A, Picard C, Wang GP, Berry CC, Martinache C, Rieux-Laucat F, Latour S, Belohradsky BH, Leiva L, Sorensen R, Debré M, Casanova JL, Blanche S, Durandy A, Bushman FD, Fischer A, Cavazzana-Calvo M (22 de xullo de 2010). "Efficacy of Gene Therapy for X-Linked Severe Combined Immunodeficiency". New England Journal of Medicine 363 (4): 355–364. PMC 2957288. PMID 20660403. doi:10.1056/NEJMoa1000164. Consultado o 13 de abril de 2013.

newscientist.com (Global: 1,041^st place; Galician: 352^nd place)

McDowell N (15 de xaneiro de 2003). "New cancer case halts US gene therapy trials". New Scientist. Arquivado dende o orixinal o 22 de outubro de 2008. Consultado o 24 de decembro de 2018.

nih.gov (Global: 5^th place; Galician: 2^nd place)

ncbi.nlm.nih.gov

Goff, S.; Berg, P. (1976). "Construction of hybrid viruses containing SV40 and λ phage DNA segments and their propagation in cultured monkey cells". Cell 9 (4): 695–705. PMID 189942. doi:10.1016/0092-8674(76)90133-1.
Hacein-Bey-Abina S, Hauer J, Lim A, Picard C, Wang GP, Berry CC, Martinache C, Rieux-Laucat F, Latour S, Belohradsky BH, Leiva L, Sorensen R, Debré M, Casanova JL, Blanche S, Durandy A, Bushman FD, Fischer A, Cavazzana-Calvo M (22 de xullo de 2010). "Efficacy of Gene Therapy for X-Linked Severe Combined Immunodeficiency". New England Journal of Medicine 363 (4): 355–364. PMC 2957288. PMID 20660403. doi:10.1056/NEJMoa1000164. Consultado o 13 de abril de 2013.
Cavazzana-Calvo, M.; Hacein-Bey, S.; De Saint Basile, G.; Gross, F.; Yvon, E.; Nusbaum, P.; Selz, F.; Hue, C.; Certain, S.; Casanova, J. L.; Bousso, P.; Deist, F. L.; Fischer, A. (2000). "Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease". Science 288 (5466): 669–672. PMID 10784449. doi:10.1126/science.288.5466.669.
Varmus, Harold; Coffin, John M.; Hughes, Stephen H., eds. (1997). "Principles of Retroviral Vector Design". Retroviruses. Plainview, N.Y: Cold Spring Harbor Laboratory Press. ISBN 0-87969-571-4.
Hacein-Bey-Abina, S.; Le Deist, F. O.; Carlier, F. D. R.; Bouneaud, C. C.; Hue, C.; De Villartay, J. P.; Thrasher, A. J.; Wulffraat, N.; Sorensen, R.; Dupuis-Girod, S.; Fischer, A.; Davies, E. G.; Kuis, W.; Leiva, L.; Cavazzana-Calvo, M. (2002). "Sustained Correction of X-Linked Severe Combined Immunodeficiency by ex Vivo Gene Therapy". New England Journal of Medicine 346 (16): 1185–1193. PMID 11961146. doi:10.1056/NEJMoa012616.
Hacein-Bey-Abina, S.; Von Kalle, C.; Schmidt, M.; McCormack, M. P.; Wulffraat, N.; Leboulch, P.; Lim, A.; Osborne, C. S.; Pawliuk, R.; Morillon, E.; Sorensen, R.; Forster, A.; Fraser, P.; Cohen, J. I.; De Saint Basile, G.; Alexander, I.; Wintergerst, U.; Frebourg, T.; Aurias, A.; Stoppa-Lyonnet, D.; Romana, S.; Radford-Weiss, I.; Gross, F.; Valensi, F.; Delabesse, E.; MacIntyre, E.; Sigaux, F.; Soulier, J.; Leiva, L. E.; Wissler, M. (2003). "LMO2-Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1". Science 302 (5644): 415–419. PMID 14564000. doi:10.1126/science.1088547.
Marini, B.; Kertesz-Farkas, A.; Ali, H.; Lucic, B.; Lisek, K.; Manganaro, L.; Pongor, S.; Luzzati, R.; Recchia, A.; Mavilio, F.; Giacca, M.; Lusic, M. (2015). "Nuclear architecture dictates HIV-1 integration site selection". Nature 521: 227–231. PMID 25731161. doi:10.1038/nature14226.
Cattoglio, C.; Facchini, G.; Sartori, D.; Antonelli, A.; Miccio, A.; Cassani, B.; Schmidt, M.; Von Kalle, C.; Howe, S.; Thrasher, A. J.; Aiuti, A.; Ferrari, G.; Recchia, A.; Mavilio, F. (2007). "Hot spots of retroviral integration in human CD34+ hematopoietic cells". Blood 110 (6): 1770–1778. PMID 17507662. doi:10.1182/blood-2007-01-068759.
Montini, E.; Cesana, D.; Schmidt, M.; Sanvito, F.; Ponzoni, M.; Bartholomae, C.; Sergi Sergi, L. S.; Benedicenti, F.; Ambrosi, A.; Di Serio, C.; Doglioni, C.; Von Kalle, C.; Naldini, L. (2006). "Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration". Nature Biotechnology 24 (6): 687–696. PMID 16732270. doi:10.1038/nbt1216.
Ramos-Kuri, M; Rapti, K; Mehel, H; Zhang, S; Dhandapany, PS; Liang, L; García-Carrancá, A; Bobe, R; Fischmeister, R; Adnot, S; Lebeche, D; Hajjar, RJ; Lipskaia, L; Chemaly, ER (2015). "Dominant negative Ras attenuates pathological ventricular remodeling in pressure overload cardiac hypertrophy". Biochim. Biophys. Acta 1853: 2870–84. PMID 26260012. doi:10.1016/j.bbamcr.2015.08.006.
McCarty, D M; Monahan, P E; Samulski, R J (2001). "Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis". Gene Therapy 8 (16): 1248–54. PMID 11509958. doi:10.1038/sj.gt.3301514.
Huang, S; Kamihira, M (2013). "Development of hybrid viral vectors for gene therapy.". Biotechnology advances 31 (2): 208–23. PMID 23070017. doi:10.1016/j.biotechadv.2012.10.001.
Nayak, S.; Herzog, R. W. (2009). "Progress and prospects: Immune responses to viral vectors". Gene Therapy 17 (3): 295–304. PMC 3044498. PMID 19907498. doi:10.1038/gt.2009.148.
Zhou, H. S.; Liu, D. P.; Liang, C. C. (2004). "Challenges and strategies: The immune responses in gene therapy". Medicinal Research Reviews 24 (6): 748–761. PMID 15250039. doi:10.1002/med.20009.
Yang, Z. -Y.; Wyatt, L. S.; Kong, W. -P.; Moodie, Z.; Moss, B.; Nabel, G. J. (2003). "Overcoming Immunity to a Viral Vaccine by DNA Priming before Vector Boosting". Journal of Virology 77 (1): 799–803. PMC 140625. PMID 12477888. doi:10.1128/JVI.77.1.799-803.2003.
Pandey, A.; Singh, N.; Vemula, S. V.; Couëtil, L.; Katz, J. M.; Donis, R.; Sambhara, S.; Mittal, S. K. (2012). Subbiah, Elankumaran, ed. "Impact of Preexisting Adenovirus Vector Immunity on Immunogenicity and Protection Conferred with an Adenovirus-Based H5N1 Influenza Vaccine". PLoS ONE 7 (3): e33428. PMC 3303828. PMID 22432020. doi:10.1371/journal.pone.0033428.

scientificamerican.com (Global: 1,110^th place; Galician: 472^nd place)

Beardsley T (febreiro de 2000). "GEne Therapy Setback.A tragic death clouds the future of an innovative treatment method". Scientific American. (require subscrición (?)).

tandfonline.com (Global: 286^th place; Galician: 323^rd place)

Sasmita, Andrew Octavian (2018-10-14). "Current viral-mediated gene transfer research for treatment of Alzheimer’s disease". Biotechnology and Genetic Engineering Reviews (en inglés): 1–20. ISSN 0264-8725. doi:10.1080/02648725.2018.1523521.

web.archive.org (Global: 1^st place; Galician: 1^st place)

McDowell N (15 de xaneiro de 2003). "New cancer case halts US gene therapy trials". New Scientist. Arquivado dende o orixinal o 22 de outubro de 2008. Consultado o 24 de decembro de 2018.

worldcat.org (Global: 4^th place; Galician: 7^th place)

Sasmita, Andrew Octavian (2018-10-14). "Current viral-mediated gene transfer research for treatment of Alzheimer’s disease". Biotechnology and Genetic Engineering Reviews (en inglés): 1–20. ISSN 0264-8725. doi:10.1080/02648725.2018.1523521.

Vector viral (Galician Wikipedia)

archive.org (Global: 6th place; Galician: 4th place)

doi.org (Global: 2nd place; Galician: 3rd place)

dx.doi.org

nejm.org (Global: 2,717th place; Galician: 1,100th place)

newscientist.com (Global: 1,041st place; Galician: 352nd place)

nih.gov (Global: 5th place; Galician: 2nd place)